-
1.
公开(公告)号:US20210052563A1
公开(公告)日:2021-02-25
申请号:US16975257
申请日:2019-02-28
IPC分类号: A61K31/4439 , A61K33/30 , A61K33/38 , A61K31/661 , A61K45/06 , A61K9/00 , A61P17/00
摘要: Embodiments of the disclosure include methods and compositions related to treatment or prevention of cancer therapy-induced tissue inflammation, dermatitis, and/or scarring. In particular embodiments one or more proton pump inhibitors are provided to an individual before, during, and/or after receiving anticancer therapy. In some embodiments one or more proton pump inhibitors are provided to an individual before, during, and/or after having a health conditions, allergies, genetic factors and/or exposure to one or more irritants.